Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Primary retroperitoneal nodal endometrioid carcinoma associated with Lynch syndrome: A case report

D. Fischerova, U. Scovazzi, N. Sousa, T. Hovhannisyan, A. Burgetova, P. Dundr, K. Němejcová, R. Bennett, M. Vočka, F. Frühauf, R. Kocian, T. Indrielle-Kelly, D. Cibula

. 2023 ; 13 (-) : 1092044. [pub] 20230221

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu kazuistiky

Perzistentní odkaz   https://www.medvik.cz/link/bmc23002863

We report a rare case of primary nodal, poorly differentiated endometrioid carcinoma associated with Lynch syndrome. A 29-year-old female patient was referred by her general gynecologist for further imaging with suspected right-sided ovarian endometrioid cyst. Ultrasound examination by an expert gynecological sonographer at tertiary center revealed unremarkable findings in the abdomen and pelvis apart from three iliac lymph nodes showing signs of malignant infiltration in the right obturator fossa and two lesions in the 4b segment of the liver. During the same appointment ultrasound guided tru-cut biopsy was performed to differentiate hematological malignancy from carcinomatous lymph node infiltration. Based on the histological findings of endometrioid carcinoma from lymph node biopsy, primary debulking surgery including hysterectomy and salpingo-oophorectomy was performed. Endometrioid carcinoma was confirmed only in the three lymph nodes suspected on the expert scan and primary nodal origin of endometroid carcinoma developed from ectopic Müllerian tissue was considered. As a part of the pathological examination immunohistochemistry analysis for mismatch repair protein (MMR) expression was done. The findings of deficient mismatch repair proteins (dMMR) led to additional genetic testing, which revealed deletion of the entire EPCAM gene up to exon 1-8 of the MSH2 gene. This was unexpected considering her insignificant family history of cancer. We discuss the diagnostic work-up for patients presenting with metastatic lymph node infiltration by cancer of unknown primary and possible reasons for malignant lymph node transformation associated with Lynch syndrome.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23002863
003      
CZ-PrNML
005      
20230421100001.0
007      
ta
008      
230413s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fonc.2023.1092044 $2 doi
035    __
$a (PubMed)36895475
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Fischerova, Daniela $u Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
245    10
$a Primary retroperitoneal nodal endometrioid carcinoma associated with Lynch syndrome: A case report / $c D. Fischerova, U. Scovazzi, N. Sousa, T. Hovhannisyan, A. Burgetova, P. Dundr, K. Němejcová, R. Bennett, M. Vočka, F. Frühauf, R. Kocian, T. Indrielle-Kelly, D. Cibula
520    9_
$a We report a rare case of primary nodal, poorly differentiated endometrioid carcinoma associated with Lynch syndrome. A 29-year-old female patient was referred by her general gynecologist for further imaging with suspected right-sided ovarian endometrioid cyst. Ultrasound examination by an expert gynecological sonographer at tertiary center revealed unremarkable findings in the abdomen and pelvis apart from three iliac lymph nodes showing signs of malignant infiltration in the right obturator fossa and two lesions in the 4b segment of the liver. During the same appointment ultrasound guided tru-cut biopsy was performed to differentiate hematological malignancy from carcinomatous lymph node infiltration. Based on the histological findings of endometrioid carcinoma from lymph node biopsy, primary debulking surgery including hysterectomy and salpingo-oophorectomy was performed. Endometrioid carcinoma was confirmed only in the three lymph nodes suspected on the expert scan and primary nodal origin of endometroid carcinoma developed from ectopic Müllerian tissue was considered. As a part of the pathological examination immunohistochemistry analysis for mismatch repair protein (MMR) expression was done. The findings of deficient mismatch repair proteins (dMMR) led to additional genetic testing, which revealed deletion of the entire EPCAM gene up to exon 1-8 of the MSH2 gene. This was unexpected considering her insignificant family history of cancer. We discuss the diagnostic work-up for patients presenting with metastatic lymph node infiltration by cancer of unknown primary and possible reasons for malignant lymph node transformation associated with Lynch syndrome.
590    __
$a NEINDEXOVÁNO
655    _2
$a kazuistiky $7 D002363
700    1_
$a Scovazzi, Umberto $u Department of Gynecology and Obstetrics, Ospedale Policlinico San Martino and University of Genoa, Genova, Italy
700    1_
$a Sousa, Natacha $u Department of Gynecology and Obstetrics, Hospital de Braga, Braga, Portugal
700    1_
$a Hovhannisyan, Tatevik $u Department of Gynecology and Gynecologic Oncology, Nairi Medical Center (MC), Yerevan, Armenia
700    1_
$a Burgetova, Andrea $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
700    1_
$a Dundr, Pavel $u Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
700    1_
$a Němejcová, Kristýna $u Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
700    1_
$a Bennett, Rosalie $u Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
700    1_
$a Vočka, Michal $u Department of Oncology, First Faculty of Medicine, Charles University, Prague, Czechia
700    1_
$a Frühauf, Filip $u Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
700    1_
$a Kocian, Roman $u Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
700    1_
$a Indrielle-Kelly, Tereza $u Department of Obstetrics and Gynecology, Burton Hospitals National Health System (NHS), West Midlands, United Kingdom
700    1_
$a Cibula, David $u Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
773    0_
$w MED00182989 $t Frontiers in oncology $x 2234-943X $g Roč. 13, č. - (2023), s. 1092044
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36895475 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230413 $b ABA008
991    __
$a 20230421095954 $b ABA008
999    __
$a ok $b bmc $g 1922692 $s 1189070
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 13 $c - $d 1092044 $e 20230221 $i 2234-943X $m Frontiers in oncology $n Front Oncol $x MED00182989
LZP    __
$a Pubmed-20230413
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace